MOTS-c: Exercise Research Without the Shortcut
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

Mitochondria do more than help supply cellular energy. Researchers also study short mitochondrial-derived peptides such as MOTS-c as possible signals between cellular processes. A 2021 paper measured MOTS-c in people around exercise. In separate experiments, the researchers gave MOTS-c to mice and assessed physical performance. That distinction is essential. Observing a molecule change during exercise does not show that taking it improves human endurance. Mouse running results cannot supply that missing human trial. FDA notes missing human exposure data for MOTS-c drug products. The research helps frame questions about metabolism and aging, while human benefits and safety remain unestablished.

END CARD
Research explained. Not medical advice. Sources and limitations in the accompanying transcript.

SOURCES
[1] Reynolds et al. (2021): MOTS-c, exercise, physical decline, and muscle homeostasis
https://www.nature.com/articles/s41467-020-20790-0
Primary mixed human-observational and animal-intervention study

[2] FDA peptide safety information: MOTs-C
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
US regulator

EVIDENCE LIMITATIONS
The human arm did not test administered MOTS-c as an exercise-enhancing treatment.
Endogenous association is not causal evidence for supplementation.
Do not substitute a modified analogue’s clinical trial for evidence on the native peptide.
No exercise-replacement, endurance, antiaging, or weight-loss promise is supported.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
https://www.facebook.com/reel/1924726701821388/